कोशिश गोल्ड - मुक्त
Roche partners with 10 govt hospitals to strengthen trials
Chronicle Pharmabiz
|September 25, 2025
ROCHE Pharma India has announced the successful completion of the first phase of its Advanced Inclusive Research (AIR) Site Alliance initiative in India, having partnered with 10 leading government hospitals from across the country and trained nearly 400 professionals including investigators, ethics committee members and support staff to global Good Clinical Practice standards.
-
The 10 sites include: AIIMS, Rishikesh, Safdarjung Hospital, New Delhi, PGIMS, Rohtak, Homi Bhabha Cancer Hospital & Research Center, Muzaffarpur, Balco Medical Centre, Raipur, Government Medical College, Aurangabad, Indira Gandhi Institute of Child Health, Bengaluru, Dr. Bhubaneswar Borooah Cancer Institute (BBCI), Guwahati, Kalyan Singh Super Speciality Cancer Institute & Hospital, Lucknow and Acharya Harihar Post Graduate Institute of Cancer, Cuttack.
The company said that it marks a significant step forward in strengthening India's readiness to participate in global and local clinical trials, enabling faster patient access to breakthrough therapies and ensuring India's diverse population is better represented in clinical research.
यह कहानी Chronicle Pharmabiz के September 25, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Chronicle Pharmabiz से और कहानियाँ
Chronicle Pharmabiz
Biocon gets US FDA nod for Bosaya & Aukelso
BIOCON Biologics, a fully integrated global biosimilars company and subsidiary of Biocon has received the US Food and Drug Administration (FDA) approval for Bosaya (denosumab-kyqq) 60 mg/mL injection for subcutaneous use in a single dose prefilled syringe (PFS), and Aukelso (denosumab-kyqq) 120 mg/1.7 mL (70 mg/mL) injection for subcutaneous use in a single-dose vial, biosimilars of Prolia and Xgeva respectively.
1 mins
September 25, 2025
Chronicle Pharmabiz
Centre to appoint 49 drug inspectors in CDSCO
THE Union Ministry of Health and Family Welfare has notified recruitment of 49 drug inspectors under the Central Drugs Standard Control Organisation (CDSCO), as part of strengthening the organisation's operations to regulate and monitor the drugs and pharmaceutical industry and market in the country.
1 min
September 25, 2025
Chronicle Pharmabiz
Cold Chain Community to hold conference in Ahmedabad
IN order to create new opportunities in the pharmaceutical cold chain sector, Cold Chain Community, a knowledge-based business platform powered by the National Accreditation Body for Cold Chain Management (NAB-CCM), will hold one-day conference on November 4, 2025 in Ahmedabad.
1 mins
September 25, 2025
Chronicle Pharmabiz
HC appoints team to conduct inspection on Palamur Bio's facility
THE Delhi High Court (HC) has appointed a three-member inspection team to conduct fresh inspection at the facility of Telan-gana-based preclinical contract research organisation Palamur Biosciences in connection with the allegations raised by the People for the Ethical Treatment of Animals India (PETA India) pertaining to abuse and neglect of animals while carrying out experimentation.
2 mins
September 25, 2025
Chronicle Pharmabiz
Merck gets 2 positive opinions from CHMP for Keytruda
MERCK, known as MSD outside of the US and Canada, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for Keytruda (pembrolizumab), Merck's anti-PD-1 therapy. One recommends approval of a new subcutaneous (SC) route of administration and a new pharmaceutical form (solution for injection) for Keytruda (pembrolizumab), which if approved would be marketed in the European Union (EU) as Keytruda SC.
1 min
September 25, 2025
Chronicle Pharmabiz
Aptar's Enbumyst receives US FDA nod
APTAR Pharma, a global leader in drug delivery and active material science solutions and services, announced that its unidose liquid system is the delivery system for the recent US FDA-approved Enbumyst (Bumetanide nasal spray) 0.5mg by Corstasis Therapeutics.
1 min
September 25, 2025
Chronicle Pharmabiz
Health insurance faces headwinds of escalating medical inflation
HEALTH insurance industry is entering a period of financial stress, driven by two critical factors.
2 mins
September 25, 2025
Chronicle Pharmabiz
NABL, Ladakh Univ team up to enhance lab capabilities
THE National Accreditation Board for Testing and Calibration Laboratories (NABL) and the University of Ladakh have partnered to enhance testing laboratory capabilities, research, and skill development in Ladakh.
1 min
September 25, 2025
Chronicle Pharmabiz
AICDF blows whistle on drug cos in U'khand
IN a bold move that could shake the pharmaceutical sector, the All India Chemists and Distributors Federation (AICDF) has submitted a scathing complaint to the National Pharmaceutical Pricing Authority (NPPA), raising serious concerns over the activities of certain drug manufacturers operating out of Uttarakhand.
2 mins
September 25, 2025
Chronicle Pharmabiz
HC appoints team to conduct inspection on Palamur Bio's facility
THE Delhi High Court (HC) has appointed a three-member inspection team to conduct fresh inspection at the facility of Telangana-based preclinical contract research organisation Palamur Biosciences in connection with the allegations raised by the People for the Ethical Treatment of Animals India (PETA India) pertaining to abuse and neglect of animals while carrying out experimentation.
2 mins
September 25, 2025
Listen
Translate
Change font size